Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP595459.RAm9te5yngu66mD6JUoLlalH8OniY_uuB7KQrJxsyrLUE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP595459.RAm9te5yngu66mD6JUoLlalH8OniY_uuB7KQrJxsyrLUE130_assertion type Assertion NP595459.RAm9te5yngu66mD6JUoLlalH8OniY_uuB7KQrJxsyrLUE130_head.
- NP595459.RAm9te5yngu66mD6JUoLlalH8OniY_uuB7KQrJxsyrLUE130_assertion description "[The results provide clinical implications that therapeutic targeting at the BRAF/MEK/MAP kinase pathway may be a good approach in restoring thyroid gene expression for effective radioiodine therapy for BRAF mutation-harboring PTC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595459.RAm9te5yngu66mD6JUoLlalH8OniY_uuB7KQrJxsyrLUE130_provenance.
- NP595459.RAm9te5yngu66mD6JUoLlalH8OniY_uuB7KQrJxsyrLUE130_assertion evidence source_evidence_literature NP595459.RAm9te5yngu66mD6JUoLlalH8OniY_uuB7KQrJxsyrLUE130_provenance.
- NP595459.RAm9te5yngu66mD6JUoLlalH8OniY_uuB7KQrJxsyrLUE130_assertion SIO_000772 17317846 NP595459.RAm9te5yngu66mD6JUoLlalH8OniY_uuB7KQrJxsyrLUE130_provenance.
- NP595459.RAm9te5yngu66mD6JUoLlalH8OniY_uuB7KQrJxsyrLUE130_assertion wasDerivedFrom befree-2016 NP595459.RAm9te5yngu66mD6JUoLlalH8OniY_uuB7KQrJxsyrLUE130_provenance.
- NP595459.RAm9te5yngu66mD6JUoLlalH8OniY_uuB7KQrJxsyrLUE130_assertion wasGeneratedBy ECO_0000203 NP595459.RAm9te5yngu66mD6JUoLlalH8OniY_uuB7KQrJxsyrLUE130_provenance.